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ABSTRACT
Nanoparticles (NPs) demonstrate promising properties as therapeutic carriers to effi ciently deliver drug molecules 
into diseased cells. The surfaces of NPs are usually grafted with polyethylene glycol (PEG) polymers, during 
 so-called PEGylation, to improve water solubility, avoid aggregation, and prevent opsonization during blood circu-
lation. The interplay between grafting density σp and grafted PEG polymerization degree N makes cellular uptake 
of PEGylated NPs distinct from that of bare NPs. To understand the role played by grafted PEG polymers, we 
study the endocytosis of 8-nm sized PEGylated NPs with different σp and N through large scale dissipative particle 
dynamics (DPD) simulations. The following results are obtained from our DPD simulations. First, for a given N, the 
internalization rate of PEGylated NPs monotonically increases with increasing σp, as the ligand–receptor interac-
tions depend linearly on σp. Second, the free energy difference of grafted PEG polymers, before and after endocy-
tosis, is found to have an effect which is comparable to, or even larger than, the bending energy of the membrane 
during endocytosis, based on our self-consistent fi eld theory. By incorporating this free energy change, the critical 
ligand–receptor binding strength for PEGylated NPs to be internalized can be correctly predicted by a simple ana-
lytical equation. Without considering the free energy change of grafted PEG polymers, it is not possible to predict 
whether the PEGylated NPs will be delivered into the diseased cells. Third, an optimal σp ~ 0.8 chains/nm
2, which 
can balance the ligand–receptor interactions with bending energy of the membrane and the free energy loss of 
grafted PEG polymers, is identifi ed through our DPD simulations for N = 18. Finally, at fi xed σp, the internalization 
rate of PEGylated NPs can be dramatically slowed by increasing N, due to the enlarged size of PEGylated NP 
and free energy change of the PEG polymers. These fi ndings pave the way for designing effi cient PEGylated NP-
based therapeutic carriers with improved cellular targeting and uptake.
